Sector: MedicalViroPharma Incorporated (NASDAQ: VPHM)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 196 |
Technical : | 122 |
Performance : | 166 |
Overall: | 189 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 194 |
Technical : | 91 |
Performance : | 117 |
Overall: | 126 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 196 |
Technical : | 77 |
Performance : | 103 |
Overall: | 107 |
Number of Stocks: | 305 |
Headlines
- Cipher appoints Dr. William Claypool to Board of Directors
Nov 03, 2009 03:50 PM | VPHM
- ViroPharma to Present at Three November Healthcare Conferences
Oct 29, 2009 04:13 PM | VPHM
- ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Oct 28, 2009 07:31 AM | VPHM
- Hereditary Angioedema (HAE) National Surveillance Project
Oct 22, 2009 03:00 PM | VPHM
- ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
Oct 15, 2009 04:00 PM | VPHM
- Viropharma (NASDAQ: VPHM): Upgraded To Outperform At Oppenheimer
Sep 28, 2009 09:33 AM | VPHM
- ViroPharma to Present at Four Additional Healthcare Conferences
Sep 15, 2009 08:31 AM | BAC, UBS, VPHM
- New Directions in Angioedema: A Focus on Supportive Care and Treatment Options
Sep 10, 2009 06:00 PM | VPHM
- ViroPharma to Present at Several Upcoming Healthcare Conferences
Sep 03, 2009 10:41 AM | VPHM
- Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting
Sep 02, 2009 08:01 AM | PFE, SNY, VPHM
- BenchmarkJournal.Com Free Analyst Review for OCNF, TSFG, PBCT, VPHM, WFMI and VALE
Aug 19, 2009 10:18 AM | OCNF, PBCT, TSFG, VALE, VPHM, WFMI
- ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
Aug 06, 2009 11:01 AM | VPHM
- ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
Aug 04, 2009 06:38 PM | VPHM
- StockPreacher.com Issues Trading Outlook for ViroPharma Inc.
Aug 04, 2009 06:51 AM | AZN, CBST, GSK, SLXP, VPHM
- ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Jul 29, 2009 07:55 AM | VPHM
- ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
Jul 14, 2009 03:58 PM | VPHM
- ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Jun 08, 2009 09:05 AM | VPHM
- ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema
Jun 04, 2009 07:31 AM | VPHM
- ViroPharma to Present at Two June Healthcare Conferences
Jun 02, 2009 03:05 PM | VPHM
- ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
May 29, 2009 10:55 AM | VPHM
- Form 4 Broom Colin MD For: Jun 11 (10K)
Jun 15, 2009 07:31 PM
- Form 4 DOYLE THOMAS F For: Jun 11 (10K)
Jun 15, 2009 07:31 PM
- Form 4 SOLAND DANIEL B For: Jun 11 (10K)
Jun 15, 2009 07:30 PM
- Form 4 Pietrusko Robert For: Jun 11 (10K)
Jun 15, 2009 07:29 PM
- Form 4 Rowland Charles A Jr For: Jun 11 (10K)
Jun 15, 2009 07:29 PM
- Form 4 MILANO VINCENT For: Jun 11 (10K)
Jun 15, 2009 07:29 PM
- Form 4 Morris Richard Steven For: Jun 11 (10K)
Jun 15, 2009 07:28 PM
- Form 4 Wolf John Peter III For: Jun 11 (10K)
Jun 15, 2009 07:28 PM
- Form 4 VIROPHARMA INC For: Jun 05 Filed by: BALDINO FRANK JR (10K)
Jun 08, 2009 03:55 PM
- Form 3 VIROPHARMA INC For: Jun 05 Filed by: BALDINO FRANK JR (10K)
Jun 08, 2009 03:55 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VPHM
|
Compare to S&P
|
| YTD |
-42.09 %
|
-49.52 %
|
| 4 Weeks |
-19.36 %
|
-20.21 %
|
| 12 Weeks |
4.14 %
|
1.56 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 70.00 %
|
|
EPS Growth in Last Year: 3.03 %
|
|
Sales Growth in Last Quarter: -1.61 %
|
|
Sales Growth in Last Quarter: 22.21 %
|
|
